Explore detailed information on the case number ORD_43328/2024 involving Novartis, Genentech and Celltrion Healthcare Netherlands, Celltrion Healthcare Deutschland, Celltrion Healthcare Hungary KFT, and others which was filed on 24 Jul, 2024.

Case Details

    Case Number:

    ORD_43328/2024

    Filing Date:

    24 Jul, 2024

    Proceeding Type:

    Order

    Action/Application:

    Generic Order

    Plaintiffs:

    • Novartis Ag
    • Genentech, Inc

    Defendants:

    • Celltrion Healthcare Netherlands B.V
    • Celltrion Healthcare Deutschland Gmbh
    • Celltrion Healthcare Hungary Kft
    • Celltrion Healthcare Belgium Sprl
    • Celltrion Healthcare Italy S.R.L
    • Celltrion Healthcare Finland Oy
    • Celltrion Healthcare France Sas

Case Decision

Decision pending - set alert to receive updates

More cases on Novartis

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_24048/2025May 20, 2025NovartisZentiva Portugal, Zentiva KS
ORD_24048/2025May 20, 2025NovartisZentiva Portugal, Zentiva KS
ORD_43329/2024Jul 24, 2024Genentech, NovartisCelltrion

More cases on Celltrion Healthcare Netherlands

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_25043/2024May 2, 2024Novartis, GenentechCelltrion Healthcare Italy, Celltrion Healthcare Netherlands, Celltrion Healthcare France, Celltrion Healthcare Deutschland, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Finland, Celltrion Healthcare Belgium
ORD_25043/2024May 2, 2024Novartis, GenentechCelltrion Healthcare Italy, Celltrion Healthcare Netherlands, Celltrion Healthcare France, Celltrion Healthcare Deutschland, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Finland, Celltrion Healthcare Belgium
ORD_22253/2024Apr 23, 2024Genentech, NovartisCelltrion Healthcare Hungary KFT, Celltrion Healthcare France, Celltrion Healthcare Netherlands, Celltrion Healthcare Deutschland, Celltrion Healthcare Italy, Celltrion Healthcare Belgium, Celltrion Healthcare Finland